Eli Lilly

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

6 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

World Politics & Diplomacy 05 Oct 2026, 03:17 AM IST

Tens of Thousands Rally Across Spain as Housing Anger Boils Over After Elderly Woman’s Eviction

Tens of thousands of people marched in Madrid and other Spanish cities on Saturday, turning a single eviction case into a broader indictment of the country’s housing crisis. The demonstrations, sparked in part by the removal of an 87-year-old woman from her home, exposed deep public frustration over soaring rents, scarce affordable housing and what protesters say is a political failure to protect tenants.

By RDU Global Wire5 min read

World Politics & Diplomacy03 Oct 2026, 10:33 PM IST

UN Says World Food Prices Near Four-Year High as Sugar and Cereal Costs Climb

Global food prices edged higher in September, approaching their highest level in nearly four years, according to the United Nations Food and Agriculture Organization. The increase was driven by firmer prices for sugar, cereals and vegetable oils, underscoring renewed pressure on import-dependent economies and households already strained by persistent inflation.

5 min readRead →

World Politics & Diplomacy03 Oct 2026, 06:30 AM IST

Pakistan Launches Deadly Airstrikes in Afghanistan, Deepening Border Crisis

Pakistan has launched airstrikes inside Afghanistan that Afghan officials and the Taliban say killed civilians, including children, in a sharp escalation along one of South Asia’s most volatile frontiers. The strikes have triggered condemnation from Kabul and renewed alarm over the risk of a wider confrontation between the two neighbors, whose relations have deteriorated over militant sanctuaries, border security and cross-border attacks.

5 min readRead →

Global Health & BiotechJust now (03:00 PM IST)

Foghorn Cuts 40% of Staff After Lilly Ends Cancer Pact on Data Concerns

Foghorn Therapeutics is laying off about 40% of its workforce after Eli Lilly terminated a cancer drug collaboration that had been a key strategic and financial pillar for the biotech company. The collapse of the partnership, reportedly tied to concerns over data quality, has intensified pressure on Foghorn’s pipeline and sent its shares sharply lower as investors reassess the company’s near-term prospects.

5 min readRead →

Global Markets & EquitiesJust now (03:47 AM IST)

Eli Lilly’s Triple-G Obesity Drug Posts Strong Early Weight Loss Even at Lowest Dose

Eli Lilly said its closely watched obesity candidate retatrutide produced substantial weight loss in a mid-stage trial, with patients on the lowest dose losing 12.7% of body weight. The result reinforces investor expectations that next-generation incretin therapies could extend the market beyond current GLP-1 leaders and intensify competition across global healthcare equities.

5 min readRead →

Global Markets & EquitiesJust now (09:54 AM IST)

Lilly’s Latest Weight-Loss Drug Drives Up to 60-Pound Loss in Diabetes Trial

Eli Lilly said its experimental triple-agonist drug retatrutide produced striking weight loss and meaningful blood-sugar improvements in people with type 2 diabetes, adding to the company’s lead in the fast-expanding obesity and metabolic disease market. The results intensify investor focus on a drug class that could reshape treatment standards and expand the commercial race against rival therapies.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Eli Lilly:

Washington, D.C.(6)United Nations Assistance Mission in Afghanistan(1)Taliban(1)Starlink(1)Spain(1)Sky News(1)